Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
NT5E (5'-Nucleotidase Ecto)
i
Other names:
NT5E, 5’-Nucleotidase Ecto, CALJA, CD73, ENT, NT5, EN, Ecto-5'-Nucleotidase, 5’-Nucleotidase, 5’-NT, NTE, 5’-Nucleotidase, Ecto (CD73), Purine 5-Prime-Nucleotidase, 5’ Nucleotidase (CD73), CD73 Antigen, E5NT, NT
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4907
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
NT5E underexpression
Urothelial Cancer
NT5E underexpression
Urothelial Cancer
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
NT5E overexpression + PD-L1 expression
Squamous Cell Carcinoma of Head and Neck
NT5E overexpression + PD-L1 expression
Squamous Cell Carcinoma of Head and Neck
PD1 inhibitor
Resistant: C3 – Early Trials
PD1 inhibitor
Resistant
:
C3
PD1 inhibitor
Resistant: C3 – Early Trials
PD1 inhibitor
Resistant
:
C3
ALK wild-type + NT5E overexpression + PD-L1 expression
Non Small Cell Lung Cancer
ALK wild-type + NT5E overexpression + PD-L1 expression
Non Small Cell Lung Cancer
toripalimab-tpzi + TJD5
Sensitive: C3 – Early Trials
toripalimab-tpzi + TJD5
Sensitive
:
C3
toripalimab-tpzi + TJD5
Sensitive: C3 – Early Trials
toripalimab-tpzi + TJD5
Sensitive
:
C3
EGFR wild-type + ALK wild-type + NT5E overexpression + PD-L1 expression
Non Small Cell Lung Cancer
EGFR wild-type + ALK wild-type + NT5E overexpression + PD-L1 expression
Non Small Cell Lung Cancer
toripalimab-tpzi + TJD5
Sensitive: C3 – Early Trials
toripalimab-tpzi + TJD5
Sensitive
:
C3
toripalimab-tpzi + TJD5
Sensitive: C3 – Early Trials
toripalimab-tpzi + TJD5
Sensitive
:
C3
NT5E overexpression
Renal Cell Carcinoma
NT5E overexpression
Renal Cell Carcinoma
sunitinib
Resistant: D – Preclinical
sunitinib
Resistant
:
D
sunitinib
Resistant: D – Preclinical
sunitinib
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.